Join
Live feed
·
INSIDERFilingvia Quantisnow
Protalix BioTherapeutics Inc. (DE) logo

Amendment: Sr. VP and CFO Rubin Eyal was granted 90,909 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PLX· Protalix BioTherapeutics Inc. (DE)
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLX (Protalix BioTherapeutics Inc. (DE)) and more on Quantisnow.

Amendment: Sr. VP and CFO Rubin Eyal was granted 90,909 shares (SEC Form 4) | Quantisnow